177 related articles for article (PubMed ID: 11809934)
1. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.
Thompson J; Stavrou S; Weetall M; Hexham JM; Digan ME; Wang Z; Woo JH; Yu Y; Mathias A; Liu YY; Ma S; Gordienko I; Lake P; Neville DM
Protein Eng; 2001 Dec; 14(12):1035-41. PubMed ID: 11809934
[TBL] [Abstract][Full Text] [Related]
2. Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins.
Hexham JM; Dudas D; Hugo R; Thompson J; King V; Dowling C; Neville DM; Digan ME; Lake P
Mol Immunol; 2001 Sep; 38(5):397-408. PubMed ID: 11684296
[TBL] [Abstract][Full Text] [Related]
3. Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1).
Woo JH; Bour SH; Dang T; Lee YJ; Park SK; Andreas E; Kang SH; Liu JS; Neville DM; Frankel AE
Cancer Immunol Immunother; 2008 Aug; 57(8):1225-39. PubMed ID: 18256829
[TBL] [Abstract][Full Text] [Related]
4. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
Ma S; Hu H; Thompson J; Stavrou S; Scharff J; Neville DM
Bioconjug Chem; 1997; 8(5):695-701. PubMed ID: 9327133
[TBL] [Abstract][Full Text] [Related]
5. Gene optimization is necessary to express a bivalent anti-human anti-T cell immunotoxin in Pichia pastoris.
Woo JH; Liu YY; Mathias A; Stavrou S; Wang Z; Thompson J; Neville DM
Protein Expr Purif; 2002 Jul; 25(2):270-82. PubMed ID: 12135560
[TBL] [Abstract][Full Text] [Related]
6. A fold-back single-chain diabody format enhances the bioactivity of an anti-monkey CD3 recombinant diphtheria toxin-based immunotoxin.
Kim GB; Wang Z; Liu YY; Stavrou S; Mathias A; Goodwin KJ; Thomas JM; Neville DM
Protein Eng Des Sel; 2007 Sep; 20(9):425-32. PubMed ID: 17693455
[TBL] [Abstract][Full Text] [Related]
7. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
[TBL] [Abstract][Full Text] [Related]
8. An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood.
Thompson J; Hu H; Scharff J; Neville DM
J Biol Chem; 1995 Nov; 270(47):28037-41. PubMed ID: 7499288
[TBL] [Abstract][Full Text] [Related]
9. Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single-chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor.
Vallera DA; Panoskaltsis-Mortari A; Jost C; Ramakrishnan S; Eide CR; Kreitman RJ; Nicholls PJ; Pennell C; Blazar BR
Blood; 1996 Sep; 88(6):2342-53. PubMed ID: 8822957
[TBL] [Abstract][Full Text] [Related]
10. Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
Wang Z; Duran-Struuck R; Crepeau R; Matar A; Hanekamp I; Srinivasan S; Neville DM; Sachs DH; Huang CA
Bioconjug Chem; 2011 Oct; 22(10):2014-20. PubMed ID: 21866954
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the anti-(human CD3) immunotoxin DT389-scFv(UCHT1) N-terminal sequence to yield a homogeneous protein.
Hexham JM; King V; Dudas D; Graff P; Mahnke M; Wang YK; Goetschy JF; Plattner D; Zurini M; Bitsch F; Lake P; Digan ME
Biotechnol Appl Biochem; 2001 Dec; 34(3):183-7. PubMed ID: 11730486
[TBL] [Abstract][Full Text] [Related]
12. Molecular modification of a recombinant anti-CD3epsilon-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model.
Vallera DA; Kuroki DW; Panoskaltsis-Mortari A; Buchsbaum DJ; Rogers BE; Blazar BR
Blood; 2000 Aug; 96(3):1157-65. PubMed ID: 10910937
[TBL] [Abstract][Full Text] [Related]
13. Treatment with immunotoxin.
Knechtle SJ
Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071
[TBL] [Abstract][Full Text] [Related]
14. Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv.
Wang Z; Kim GB; Woo JH; Liu YY; Mathias A; Stavrou S; Neville DM
Bioconjug Chem; 2007; 18(3):947-55. PubMed ID: 17352456
[TBL] [Abstract][Full Text] [Related]
15. Effect of pre-existing anti-diphtheria toxin antibodies on T cell depletion levels following diphtheria toxin-based recombinant anti-monkey CD3 immunotoxin treatment.
Matar AJ; Pathiraja V; Wang Z; Duran-Struuck R; Gusha A; Crepeau R; Tasaki M; Sachs DH; Huang CA
Transpl Immunol; 2012 Aug; 27(1):52-4. PubMed ID: 22676970
[TBL] [Abstract][Full Text] [Related]
16. GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials.
Woo JH; Liu JS; Kang SH; Singh R; Park SK; Su Y; Ortiz J; Neville DM; Willingham MC; Frankel AE
Protein Expr Purif; 2008 Mar; 58(1):1-11. PubMed ID: 18160309
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of anti-CD3 diphtheria immunotoxin in CD3 positive T-cell lymphoma trials.
Woo JH; Lee YJ; Neville DM; Frankel AE
Methods Mol Biol; 2010; 651():157-75. PubMed ID: 20686966
[TBL] [Abstract][Full Text] [Related]
18. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9.
Huang CA; Yamada K; Murphy MC; Shimizu A; Colvin RB; Neville DM; Sachs DH
Transplantation; 1999 Sep; 68(6):855-60. PubMed ID: 10515387
[TBL] [Abstract][Full Text] [Related]
19. Recombinant anti-monkey CD3 immunotoxin depletes peripheral lymph node T lymphocytes more effectively than rabbit anti-thymocyte globulin in naïve baboons.
Wamala I; Matar AJ; Farkash E; Wang Z; Huang CA; Sachs DH
Transpl Immunol; 2013 Dec; 29(1-4):60-3. PubMed ID: 24157659
[TBL] [Abstract][Full Text] [Related]
20. Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18.
Hamawy MM; Tsuchida M; Cho CS; Manthei ER; Fechner JH; Knechtle SJ
Transplantation; 2001 Aug; 72(3):496-503. PubMed ID: 11502982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
